All posts by atascientific

5 Reasons to Combine Laser Diffraction Particle Sizing and Image Analysis

Particle size is by far one of the most important physical properties of particulate samples. The measurement of particle size distribution is routinely carried out across a wide range of industries for mainly two reasons; to better understand how particle size will affect their product performance and to optimise and control the quality of products and processes during manufacturing.

In addition to particle size, the shape or morphological surface properties of the particles can be equally as important or even interrelated eg. surface area and particle size. The size and shape of a particle can influence a variety of material properties. From dissolution rates of tablets, stability of paints, the texture of foods and coatings, to the flowability and packing density of powders, understanding particle size and shape can be critical when designing a product for a particular purpose or behaviour.

Why measure particle size using laser diffraction?

Laser diffraction technology for routine particle size analysis remains the method of choice across a diverse range of industrial sectors.  The speed and ease of use of this technology and the wide dynamic range (nm to mm)1 give users access to quick, reliable particle size data with minimal effort. 

Laser diffraction is a non-destructive ensemble technique, meaning it calculates particle size distribution for the whole sample rather than building up a size distribution from measurements of individual particles. A sample, dispersed either in solution or fed dry which is passed through a collimated laser beam, scatters light over a range of angles. Large particles generate a high scattering intensity at relatively narrow angles to the incident beam, while smaller particles produce a lower intensity signal but at much wider angles. Laser diffraction analysers like the Mastersizer 3000 record the angular dependence of the intensity of light scattered by a sample, using an array of detectors. The range of angles over which measurements are made directly relates to the particle size range which can be determined in a single measurement2

However, particles are 3-dimensional objects, and unless they are perfect spheres (e.g. emulsions or bubbles), they cannot be fully described by a single dimension such as a radius or diameter3. Therefore, to simplify the measurement process particle size is defined using the concept of equivalent spheres. The equivalent sphere concept works very well for regular-shaped particles, but for particles that are shaped like needles or plates, the size in at least one dimension can differ significantly from that of the other dimensions.

For this reason, many groups also employ low-cost sieve analysis to evaluate the large particle content. However, in addition to being slow and manually intensive, sieving lacks sensitivity at the fine fraction of the distribution, particularly at < 38 µm which is known as the sub-sieve size region4. Excessive fines in this size range tend to cause attraction or bridging of particles and are often combined with humidity or sticking issues. Wet sieving may help, but screen blocking is still common especially in smaller sizes.  Laser diffraction using wet or dry dispersion methods overcomes these issues and enables faster, simpler analysis with better resolution and control of agglomerates. 

How can imaging help measure particle size more accurately?

Imaging allows users to visually see the particles to determine particle size and shape and is complementary to laser diffraction particle sizing, allowing more data to be collected and measured. 

The Hydro Insight is a dynamic imaging tool that sits alongside the Mastersizer 3000 particle size analyser. It provides real-time images of individual particles as well as quantitative data on particle shape at the same time as laser diffraction size measurements. Particles dispersed by the Mastersizer 3000’s wet accessories flow through the Hydro Insight and are then photographed by a high-resolution digital camera at up to 127 frames per second. The camera takes images of the suspended particles in the analysis cell, converts them to a digital format, and sends the information to the software for final analysis in real-time. Individual particle images are viewed directly and captured as image files for post-run processing. More than 30 size and shape metrics available such as circularity, ellipticity, opacity, mean diameter, and aspect ratio allows the user to understand how the combination of particle size and shape affects material behaviour. 

Adding the Hydro Insight to your Mastersizer 3000, combines shape data with size data to enable the following benefits:  

#1 Gain a deeper understanding of why materials behave the way they do 

Hydro Insight provides real-time images of liquid dispersions of individual particles to provide quantitative data on particle shape. Circularity and aspect ratio (width and length) can be used to distinguish between particles that have regular symmetry, such as spheres or cubes, and particles with different dimensions along one axis, such as needle shapes. Other shape parameters that can be used to characterise particle form include elongation and roundness. This plays a significant role in applications such as powder processes where size and shape can influence powder flowability/ blending properties, cohesion/ formation of agglomerates, tableting/ compaction behaviour, porosity/ reactivity, and even health and safety. When assessing pharmaceutical drug products the size and shape of particles can influence drug delivery within the body, dissolution behaviour, bioavailability, and drug efficacy. 

#2 Speed up method development

When setting up a method to measure particle size using laser diffraction, achieving optimal dispersion is important to prevent agglomerates and to ensure the reproducibility of results. This can involve multiple steps from varying the dispersant type or amount of surfactant to the amount of mechanical mixing or ultrasound needed. By combining size analysis with imaging, particles can be seen live in a liquid and any agglomerates that form can quickly be identified and dispersed using optimal conditions. Users can see their dispersion as they develop laser diffraction methods, saving time for other projects.

#3 Build confidence in product quality

Laser diffraction is an ensemble technique able to measure particle size and particle size distribution for a wide range of samples over a wide dynamic range. However, for materials that require narrow polydispersity, the presence of just a few large or outlying particles can make a big difference to their performance. Large particles can block printing nozzles or cause imperfections in coatings or even be a source of immunogenicity when developing pharmaceutical drugs. Adding the Hydro Insight to the Mastersizer 3000 provides images of individual particles and gives a number-based particle size distribution, so it becomes sensitive to even small numbers of oversized particles leading to enhanced resolution. 

#4 Quickly troubleshoot

Laser diffraction offers a simple, fast, and reproducible technique to measure particle size reliably; however, samples can sometimes present results that are unexpected, contain artifacts or simply be “out of spec”. Looking at your material on a microscope often needs a different sample preparation method and that can make the picture more complicated. 

By adding imaging to laser diffraction workflows, the process of troubleshooting can be automated and therefore speed up analytical processes. With Hydro Insight, any anomalies in results can be assessed to determine whether they were caused by oversized particles, agglomerates, bubbles, or something else.

#5 Faster method transfer

Sieving is one of the oldest and simplest techniques for separating particles based on their size. However, the time it takes to obtain accurate results, the poor resolution, and problems associated with particle agglomeration and sieve blockage, have seen sieving being replaced in most industries with laser diffraction. Laser diffraction and sieving can provide similar results when characterising spherical or semi-spherical particles, however, differences can be observed for non-spherical particles because each technique measures different particle properties. Laser diffraction measures light scattering from a group of particles and reports size as a volume distribution of spheres that would produce the recorded pattern. In comparison to sieving, a mixture of size, shape, and density generates a weight distribution. Therefore using sieving, an elongated particle will be reported using the smaller dimension and will appear smaller when compared to laser diffraction results.  

The Hydro Insight provides a window or a set of eyes into the Mastersizer. It records thumbnail images of a dispersion of particles and measures quantitative particle shape data. It can report different size parameters for irregular particles such as particle width and elongation data that may correlate better with sieve analysis and thus simplify the transfer process from sieves to laser diffraction.  

Laser diffraction provides fast, reproducible particle size data for a range of applications. Image analysis is often used in combination with laser diffraction to provide a further understanding of how materials behave as well as being an orthogonal technique that helps with method validation.

So why choose the MASTERSIZER 3000 with the Hydro Insight?

The MALVERN MASTERSIZER 3000 system has a unique, compact design that uses laser diffraction to measure particle size distribution. The Hydro Insight sits alongside the Mastersizer 3000 and provides real-time images of particles, as well as quantitative particle shape data. This enables users to gain a deeper understanding of their products for easier troubleshooting and quicker method development.  Learn more about the Malvern Mastersizer 3000 and Hydro Insight system, speak to ATA Scientific today.

You are invited to attend QSense User Days, 2-3 November 2021

Join us for two days of inspirational and educational sessions on the topic of QCMD. During this event, you will have the opportunity to meet other users and learn more about the study of biomolecular interactions using QSense in a range of applications such as the biomedical, pharma and food industry. 

The agenda includes technical training sessions to help build QCMD user skills and learn best practices on both the QSense hardware and software. Selected sessions will also be available following the event, for all those that register. 
Register Now – Click here

DOWNLOAD THIS CASE STUDY
QSense was used to analyse and quantify the adsorption of therapeutic monoclonal antibodies and proteins to different materials and interfaces. The impact of the material, the effect of sample concentration and presence of surfactants on the surface uptake was also quantified.
 
DOWNLOAD THIS OVERVIEW
Lipid-based systems
are widely used in the design and development of biosensor platforms, biomaterial coatings and drug delivery applications. Here we present examples of how these lipid-based systems can be analysed using QSense QCM-D technology.
We are ready and waiting to answer your questions – Contact us       
Are you looking for more information on one of our instruments or currently need assistance with your sample analysis. Please contact us and one of our specialists will assist you. 

Creating a Genetic Medicine Manufacturing Ecosystem: Part 2

by Peter Davis (ATA Scientific, Sales and Applications support)

Creating a Genetic Medicine Manufacturing Ecosystem part 2

In the April / May 2021 issue of Lab + Life Scientist1  I wrote about the need to create a Genetic Medicine Ecosystem. I am humbled to hear it has had some level of impact. The landscape has shifted from a hopeless pipe dream to firm steps and to the creation of such an ecosystem, from the unlikeliest places. There has been a maturation of groups fundamental to the success of such a concept, and formalised structures in the design stage. State governments may be the key to the ecosystem dilemma, given the apparent lack of action federally to date! So, let’s dive in and learn what’s been happening since then.

Whilst I was delivering a genetic medicine seminar on the 21st of April at the Doherty Institute, the Victorian Government weighed into the national void by investing a whopping $50M to advance the production of a COVID-19 vaccine. This kicked the nation into overdrive, seemingly caught other governments by complete surprise, and buoyed the Australian RNA Production Consortium (ARPC).

The master plan of a complete ecosystem enjoyed some tinkering around the edges by Therapeutic Innovation Australia, involved in an RNA production Facility at the University of QLD.  This is a much-needed initiative for one of the puzzle pieces.

The Australian Government has at last embarked on a plan with ‘Australia’s onshore mRNA manufacturing capability: approach to market’ led by the Department of Industry, Science, Energy and Resources.

“Building on the success of COVID-19 mRNA vaccines, the Australian Government recognises that mRNA technology is part of the next generation in advanced health care… On 21 May 2021, the government opened this approach to market. It enables manufacturers who can provide mRNA manufacturing capability in Australia to plan a partnership approach with the government to bring forward this capability.” 2 

On the face of it, this looks like a fabulous initiative but will need careful planning given the enormity of the project, requiring an end-to-end, onshore population-scale mRNA capability to be fully operational within a short time frame. Respondents were given only 8 weeks to apply to the approach to market as it closed on the 16th of July. This is an onerous task for smaller biotech companies which may leave only big pharma capable of responding.  I wait with interest to see if this will be the full ecosystem we are anticipating. Interestingly, the Government may elect not to invest nor have they postulated the investment value. The research community is highly sceptical of this. Will the organisation granted access to this funding be a champion for the research community? Perhaps the grant should force local research collaboration given this is where the most amazing discoveries arise from, ideally it should have researcher governance.

ANZ Alliance and the Australian Academy of Science (AAS)
The ARPC has advised governments on so many levels, it is nice to see they have collaborated with our friends in New Zealand. Now they are ANZRPC. A little over a year ago, 6 motivated and highly driven scientists from across Australia come together to promote the opportunity to manufacture genetic medicines locally, now having the support of The Australian Academy of Science. They collaborated with the AAS for a round table eventwhich resulted in a Statement – National RNA science and technology priorities4.

“The agreed recommendations from the roundtable are to advance opportunities towards:

• a national mission for the whole RNA science and technology pipeline in Australia, driven by strategic investment and prioritisation across funding schemes. The national mission should provide sustainable, long-term funding for projects from fundamental research to translation

• a local mixed RNA manufacturing ecosystem, including pilot facilities to enable new Australian products to be translated, production of pre-clinical trial components and GMP sovereign manufacturing capability to support clinical trials

• the formalisation of cross-disciplinary coordination to: develop a roadmap for a national RNA science and technology mission; holistically nurture the entire research to translation pipeline; connect the research community to each other and industry

• the facilitation of commercialisation and establishment of a self-sustaining RNA biotech industry through new and existing mechanisms, including incentivising the capture of new intellectual property, the R&D tax incentive and proposed patent box initiative

• schemes to build capacity in entrepreneurial and translation expertise, including facilitating greater mobility between research and industry”4

Looking at these recommendations through the lens of a future for STEM, young researchers, local manufacturing and sovereign capacity, they are on target and a scream to the Government NOT to lock up funding with a self-serving corporate entity without interest in engaging with basic research.

The pedigree of the participants is a formidable list of outstanding researchers. The observers to this event were fortunate to witness what will go down in history as one of those rare events of immense importance.

Monash makes a move
Professor Colin Pouton was awarded $5Million from the Victorian government to progress his COVID-19 Vaccine to the clinic. It was exciting to see Colin explain his vaccine concept during the BioForum5 recently. This forum was made possible by the BioMelbourne Network with mRNA Victoria as collaborators for the event plus sponsors State Government of Victoria, Department of Jobs, Precincts and Regions and I should acknowledge the speakers – The Hon. Jaala Pulford, Professor Colin Pouton and Dr Amanda Caples. This is no pipedream – the reality is they acquired a NanoAssemblr Blaze for phase 1 clinical trials at IDT Australia (Institute of Drug Technology Limited) – A publicly listed Australian cGMP pharmaceutical manufacturing company based in Melbourne. What a monumental step toward securing local manufacturing led by the researcher! The Victorian Government should be applauded for such an initiative.

Then UNSW arrives
The UNSW RNA Institute will be a science, therapeutics and translational facility driving cross-disciplinary approaches to global challenges in RNA chemistry, biology and medicine. It will be established with a $25 million investment from UNSW as part of a collaborative, RNA Bioscience alliance between NSW universities. Another ARPC founder Professor Pall Thordarson from UNSW Science will lead the UNSW RNA Institute. “An mRNA manufacturing capability would position Australia as a leader in the global research effort to combat emerging vaccine-resistant viruses, such as new COVID-19 variants” …. “More importantly, this is not just about mRNA vaccines. They are only the tip of the iceberg in terms of a whole range of RNA therapeutics that are revolutionising medicine – a field that UNSW has great strengths in and includes novel cancer treatments and RNA-based treatments against the virus that causes COVID-19.”6

In partnership with NSW Health, UNSW will also lead the NSW RNA Production and Research Network. This Network brings together four universities – The University of Sydney, University of Technology Sydney, Macquarie University and the Australian National University – plus several medical institutes and hospital-based facilities with the UNSW RNA Institute, to enable an RNA community of practice in NSW/ACT6.

Delta rages – in a word… VACCINATE!
As Australia comes to grips with a fresh COVID-19 outbreak of the Delta variant, NSW has stepped up and run hard to vaccinate. The way forward to some semblance of normality is clearly vaccination. Companies are scrambling to resolve their approach to manage this situation. Some are attempting to mandate vaccination; others are taking more carrot than stick tactic, where access will require certified two jabs. Such a passport scheme appears to be effective in encouraging ambivalent people to step up and expose their arm. Whether it’s a ‘vaxed’ or a vexed issue, even the ‘Fair Work Ombudsman has updated its guidelines stating that employers can “direct” employees to get vaccinated where it is “lawful and reasonable”. ‘8 What does this mean, and who judges this?

As with many things in life, the key is education, and this cannot be clearer than looking at the ATA Scientific example. We are boasting a high vaccination rate without any encouragement from management. The status will be 100% soon as the vaccination appointments come along. This prompts me to consider why are we finding 100% relatively easily as the national percentage of fully vaccinated is approximately 36%9 – perhaps it is what we do.
 
ATA Scientific supplies instruments to the medical research industry. We are immersed in vaccine research, genetic medicine, COVID treatment research and so much more. We are proud to play our small part in Australia’s response.  Not all our team were immune to the prevailing virus of social media rabbit holes, however requiring a little vaccine 101 and an explanation of how mRNA works.  We certainly are fortunate we can reference peer-reviewed research, and many of these researchers are our direct customers and friends.

Much has been said about the current batch of mRNA Vaccines, specifically developed too fast to trust. The idea that these vaccines came out of nowhere is a failure of scientific communication. They are based on decades of research across multiple fields. This link to the 2020 Nobel Laureate Dr. Michael Houghton on Lipid Nanoparticle RNA Vaccines7 describes the journey of mRNA vaccine development eloquently.

And we wait
I concluded my first genetic medicine ecosystem article calling for funding to back the ARPC vision. I borrowed a phrase from Prof Archa Fox ‘the opportunity is there – we just must be bold and grasp it with both hands.’  Let’s grasp the opportunity the Victorian and NSW governments have bestowed, look to the future and all the possibilities from this amazing journey so far and make Australia a global powerhouse of scientific research, democratising medicine!

References:

  1. https://issuu.com/westwick-farrowmedia/docs/lab_and_life_scientist_apr_may_2021 Page 6. Accessed 23 Aug 2021
  2. Department of Industry, Science, Energy and Resources. Australian Government. Accessed 1 July 2021 https://www.industry.gov.au/news/enabling-australias-onshore-mrna-manufacturing-capability-approach-to-market
  3. https://www.science.org.au/news-and-events/news-and-media-releases/can-australia-emerge-covid-19-pandemic-and-build-world-leading-rna-science-based-biotech-industry Accessed 24 Aug 2021
  4. Statement – National RNA science and technology priorities
    https://www.science.org.au/files/userfiles/support/documents/statement-national-rna-science-and-technology-priorities.pdf
  5. https://biomelbourne.org/bioforum-future-direction-for-mrna-technology-meeting-recording/ Accessed 24 Aug 2021
  6. New UNSW institute to spearhead NSW government drive for RNA research: https://newsroom.unsw.edu.au/news/science-tech/new-unsw-institute-spearhead-nsw-government-drive-rna-research Accessed 24 Aug 2021
  7. RNA LNP Vaccines Overview – Dr. Michael Houghton https://www.youtube.com/watch?v=h3YeC04IxnI Accessed 24 Aug 2021
  8. https://www.abc.net.au/news/2021-08-22/covid-19-frequently-asked-questions-coronavirus-most-asked-2/100394856 . Site accessed 23 August 2021.
  9. https://www.health.gov.au/sites/default/files/documents/2021/08/covid-19-vaccine-rollout-update-jurisdictional-breakdown-22-august-2021.pdf Site accessed 23 August 2021

OUR STAFF ARE VACCINATED FOR COVID19 AND READY TO SUPPORT YOU

As the delta variant of COVID-19 takes hold, the way forward to some semblance of normality is clearly vaccination. Some companies are attempting to mandate vaccination; others are taking more carrot than stick tactic where access will require certified two jabs.

We at ATA Scientific are proud to announce a high vaccination rate without any encouragement from management. The status will be 100% soon as the vaccination appointments come along. This prompts us to consider why are we finding 100% vaccination relatively easily as the national percentage of fully vaccinated is approximately 36% –  perhaps it is what we do.
 
ATA Scientific supplies analytical instruments to a wide field including the medical research industry. We are immersed in vaccine research, genetic medicine, COVID treatment research and so much more. We are proud to play our small part in Australia’s response.

Take a look at our recent NanoAssemblr installation at IDT currently being used to manufacture our first mRNA vaccine in Australia  CLICK HERE


To speak to one of our friendly staff or for further information, please contact us. 
CONTACT US TODAY
 
DID YOU KNOW WE SERVICE AND SUPPORT ALL OUR INSTRUMENTS LOCALLY?
 
We provide local instrument maintenance and service
 
We provide on-going help with training & method development
 
We provide educational seminars and application support 

We listen to your requirements and supply the most suitable technology for your application  

CONTACT US TODAY    

ATA Scientific has developed a COVID-19 Customer Response Plan to help those that require analytical testing services adapted to the remote working environment. Our technical support and service team is ready to support you remotely with web-based demonstrations, online operator training, service support, contract sample testing and instrument hire.

Find out more about our support services here


DAY IN THE LIFE OF A RESEARCH STUDENT IN 60 SECONDS! 

If you are a young scientist you can enter our competition to win one of six $500 Encouragement Awards. This award is intended to provide you with financial assistance to attend a relevant science conference or to further your research or studies.   

CLICK HERE TO ENTER OUR AWARD

DAY IN THE LIFE OF A RESEARCH STUDENT IN 60 SECONDS!

If you are a young scientist you can enter our competition to win one of six $500 Encouragement Awards. This award is intended to provide you with financial assistance to attend a relevant science conference or to further your research or studies.  

MAKE A VIDEO COMPETITION

Most people are aware of the impact the pandemic has had on the general economy, but we don’t hear much from students themselves on how it has impacted their life. The shift to hybrid learning has become the norm so now it is time for us to reconnect with you as a student, and see the world from your point of view.

We invite you to create a video that showcases a typical day in your life as a student, using one of the options below:
 
Option 1: 
Create a ‘tiktok’ style video that showcase what you typically do in a day or week in the lab? For example, this can include a video collage showing snippets of your experiments, from pippetting to data analysis etc. 
OR
Option 2: 
Present a “60 second thesis” style talk to describe your research project. This option is based on the idea of the 3 min thesis, where you explain your thesis and demonstrate what is novel in 3 mins. However instead of 3 minutes, we challenge you to create a 60 second video to do this instead.  Top six winners will receive A$500 award each.  

Entries close 8 October 2021

CLICK HERE TO ENTER  

Phenom Pharos G2 Desktop Field Emission Scanning Electron Microscope (FEG-SEM)

Phenom Pharos G2 Desktop Field Emission Gun – Scanning Electron Microscope (FEG-SEM) provides high-resolution imaging of a variety of materials on a fast and easy-to-use tabletop system.
Fully integrated advanced detectors acquire high-quality images up to 2 million times in magnification, at 2.0 nanometer (nm) resolution and up to 20 kilovolts (kV). Users can also image soft, beam-sensitive or insulating samples at energy levels as low as 1 kV, obtaining high-resolution views into polymers and multilayer organic films without damaging or obscuring their nanoscale features.


Sensitive materials require gentle conditions. With an acceleration voltage down to 1 kV, the Phenom Pharos G2 Desktop FEG-SEM images beam-sensitive samples without sample coating or other sample preparation. Left: pharmaceutical powder, imaged without damage at 1 kV. Right: the same sample imaged at 5 kV, with damage, illustrating the need for low-kV imaging.

PHENOM PHAROS G2 FEG-SEM DELIVERS
* High-resolution imaging: 2.0 nm resolution
* A wide acceleration voltage range of 1-20 kV to image a wide range of samples.
* Integrated low / medium / high vacuum modes
* Images can be obtained in <30 seconds for high sample throughput.
* Ease-of-use with an intuitive user interface on a widescreen, 24-inch monitor 
* Quick installation (40% faster than the previous version) speeding time to results.
* Integrated power supply and robust parts designed to ensure reproducible data

CALL US FOR A PERSONAL DEMONSTRATION
Bookings are available now. Should you wish to use this instrument, simply contact us

Fast, label-free techniques for assessing biomolecular stability and efficacy of gene therapies and vaccines

In this newsletter we highlight the latest analytical tools from Malvern Panalytical to help produce safe, reliable, high quality products and accelerate discovery through to manufacturing and process control. 
Size-exclusion Chromatography (SEC), together with compositional analysis, can determine concentration and molecular weight of two distinct components. Differential scanning calorimetry (DSC) on the other hand, is a fundamental tool for characterising proteins and plays a key role in understanding thermal and conformational stability. Learn in detail how these 2 techniques play a crucial role in your development processes.

WATCH THE ON DEMAND WEBINAR SERIES BELOW 

Should you wish to discuss an analytical technique or a specific analytical instrument, simply contact us: by phone 02 9541 3500 or send your questions, comments and feedback to enquiries@atascientific.com.au  

CLICK HERE TO BOOK A FREE CONSULTATION OR DEMO TODAY

 
Using SEC and DSC to optimise loading time and stability of Virally Vectored therapies and vaccines.
WATCH WEBINAR 3


Using MADLS and NTA for quick, label-free measurements of rAAV aggregation, capsid charge, and particle concentration.
WATCH WEBINAR 2  


Comprehensive overview of rapid, label-free characterisation methods using DLS, DSC, NTA, SEC. 
WATCH WEBINAR 1

ATA Scientific has developed a COVID-19 Customer Response Plan to help those that require analytical testing services adapted to the remote working environment. 
Find out more about our support services – click here
Contact us for a demo
Request a quote now
Email us for more info

10% discount on all Theta Flow systems. Limited time until the end of Sept 2021!

To celebrate the new release, we are offering a 10% discount on all Theta Flow systems for a limited time until the end of September 2021!  

New Attension Theta Flow brings simplicity into demanding surface research

This premium contact angle meter integrates a high level of automation to simplify measurements and increase accuracy. Theta Flow offers: Camera autofocus and auto surface mapping to help simplify measurements and improve accuracy. 5MP camera and DropletPlus technology enable image enhancements. Tilt/level sensors, temperature/ relative humidity sensors ensure traceable and reliable data. The new touch display assists users by simplifying the measurement setup.   

CLICK HERE: Find out more about our one-time launch offer.  
Request a quote now
Visit our website here
Contact us for more info
 

DO YOU USE JAR TESTING FOR YOUR WATER TREATMENT PROCESS?

Control of the flocculation process and adjustment of coagulant dose is often a challenging step in the water treatment process. Chemicals used can be expensive. Add too much and they can alter your water’s pH; add too little and they don’t do the job of coagulating the flocculation.

This webinar discusses how your plant can use Zeta Potential technology in the lab or as a smart online monitoring tool. See how it can be used to understand the effect of the coagulant dose used in pre-treatment processes to enable a floc to form and allow filtration to work efficiently.
  WATCH WEBINAR NOW
 
Webinar Q&A – Read replies here

Given the influx of questions received during the Q&A session, we have listed our answers in this recent article online.
Contact us for more 


Zetasizer WT brochure

Download a copy of the brochure here   Zeta potential is a simple physical technique based on light scattering used to assesses the net charge of particles and offers a faster more efficient method for optimising coagulant dosage
compared to traditional jar tests.
To learn more – CLICK HERE
 
Click here: 
Discover how Severn Trent, a leading UK water company, is using the Zetasizer off- and online to reduce operational risk and coagulant costs, and establish a robust platform for automated clarification control.

Click here: 
See how water treatment plants like the USA’s One Aurora Water treatment facility, is using zeta potential as both an off- and on-line tool.    We offer a broad range of products and services, focused in the areas of Particle, Material, Biomolecular Sciences and SEM/ Imaging. For a free consultation and quote, please get in touch.
Request training or a demo
Click here for sample testing
Click here for service support

IDT expands commercial scale pharmaceutical manufacturing

IDT Australia*,(Institute of Drug Technology Limited) recently installed their new Avestin EmulsiFlex C55. With a flow rate of up to 55L/hr, this system bridges the gap between a benchtop and production scale high pressure homogeniser that can be applied to cell disruption (Bacteria, Yeast, Algae, Insect and Mammalian cells), liposomal products, emulsions and particle size reduction.

A unique “dynamic” homogenising valve and no “O”-rings or gaskets in the entire path of the product, means less risk for contamination or blockage. The C55 is versatile in terms of suitable sample sizes, processing a minimum sample volume of only 100mL and allowing for adjustable flow rates down to ~18L/hr and temperature control. The system is suitable for GMP compliance as well as compliance to 21 CFR Part 11.

*IDT is an Australian cGMP pharmaceutical manufacturing company that specialises in high containment, high potency manufacture of Active Pharmaceutical Ingredients (API) and Finished Dose Forms (FDF), as well as offering a full suite of contract manufacturing services. 

For more information on the Avestin range and accessories, please contact us below:
Contact us for more information    
Other popular high pressure homogenisers used to efficiently reduce particles and droplets from micron to nanometer sizes include:
 
Avestin Emulsiflex C5 is a lab scale, air driven, high pressure homogeniser.
 
Avestin Emulsiflex C3 is a lab scale, electric motor driven, high pressure homogeniser.
Request a call back
Request sample testing
Request service or support